84 related articles for article (PubMed ID: 19011184)
1. Role of PET in the initial staging of cutaneous malignant melanoma: systematic review.
Krug B; Crott R; Lonneux M; Baurain JF; Pirson AS; Vander Borght T
Radiology; 2008 Dec; 249(3):836-44. PubMed ID: 19011184
[TBL] [Abstract][Full Text] [Related]
2. PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse.
Autilio C; Paolillo C; Lavieri MM; Pocino K; De Paolis E; Di Stasio E; Marchetti P; Gian Carlo CA; Capoluongo E
Oncotarget; 2017 Oct; 8(49):85479-85491. PubMed ID: 29156734
[TBL] [Abstract][Full Text] [Related]
3. The Reporting and Methodological Quality of Systematic Reviews Underpinning Clinical Practice Guidelines Focused on the Management of Cutaneous Melanoma: Cross-Sectional Analysis.
Khalid M; Sutterfield B; Minley K; Ottwell R; Abercrombie M; Heath C; Torgerson T; Hartwell M; Vassar M
JMIR Dermatol; 2023 Dec; 6():e43821. PubMed ID: 38060306
[TBL] [Abstract][Full Text] [Related]
4. Schwannomas mistaken for metastases of melanoma in PET-CT: A diagnostic challenge with consequences.
Hirsiger S; Olariu R
Clin Case Rep; 2022 Dec; 10(12):e6753. PubMed ID: 36583202
[TBL] [Abstract][Full Text] [Related]
5. Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies.
Newcomer K; Robbins KJ; Perone J; Hinojosa FL; Chen D; Jones S; Kaufman CK; Weiser R; Fields RC; Tyler DS
Curr Probl Surg; 2022 Jan; 59(1):101030. PubMed ID: 35033317
[No Abstract] [Full Text] [Related]
6. PET Imaging of VLA-4 in a New BRAF
Bellavia MC; Nyiranshuti L; Latoche JD; Ho KV; Fecek RJ; Taylor JL; Day KE; Nigam S; Pun M; Gallazzi F; Edinger RS; Storkus WJ; Patel RB; Anderson CJ
Mol Imaging Biol; 2022 Jun; 24(3):425-433. PubMed ID: 34694528
[TBL] [Abstract][Full Text] [Related]
7. Precision Nuclear Medicine: The Evolving Role of PET in Melanoma.
Wright CL; Miller ED; Contreras C; Knopp MV
Radiol Clin North Am; 2021 Sep; 59(5):755-772. PubMed ID: 34392917
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous malignant melanoma with rarest combination of prostatic and splenic metastases on fluorodeoxyglucose (FDG) positron emission tomography-computed tomography scan.
Shah D; Odedara P
World J Nucl Med; 2020; 19(3):273-276. PubMed ID: 33354185
[TBL] [Abstract][Full Text] [Related]
9. Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.
Pyo A; Kim DY; Kim H; Lim D; Kwon SY; Kang SR; Kim HS; Bom HS; Min JJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12991-12999. PubMed ID: 32439710
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and validation of [
Wichmann CW; Goh YW; Parslow AC; Rigopoulos A; Guo N; Scott AM; Ackermann U; White JM
EJNMMI Radiopharm Chem; 2020 Jan; 5(1):3. PubMed ID: 31974638
[TBL] [Abstract][Full Text] [Related]
11.
Zhang C; Zhang Z; Merkens H; Zeisler J; Colpo N; Hundal-Jabal N; Perrin DM; Lin KS; Bénard F
Sci Rep; 2019 Sep; 9(1):13575. PubMed ID: 31537869
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.
Dinnes J; Ferrante di Ruffano L; Takwoingi Y; Cheung ST; Nathan P; Matin RN; Chuchu N; Chan SA; Durack A; Bayliss SE; Gulati A; Patel L; Davenport C; Godfrey K; Subesinghe M; Traill Z; Deeks JJ; Williams HC;
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012806. PubMed ID: 31260100
[TBL] [Abstract][Full Text] [Related]
13. Melanoma & nuclear medicine: new insights & advances.
Perissinotti A; Rietbergen DD; Vidal-Sicart S; Riera AA; Olmos RAV
Melanoma Manag; 2018 Jun; 5(1):MMT06. PubMed ID: 30190932
[TBL] [Abstract][Full Text] [Related]
14. Melanoma and nuclear medicine.
Perissinotti A; Vidal-Sicart S; Nieweg O; Valdés Olmos R
Melanoma Manag; 2014 Aug; 1(1):57-74. PubMed ID: 30190811
[TBL] [Abstract][Full Text] [Related]
15. Atypical spleen tuberculosis in a melanoma patient accidentally detected during a
Cegla P; Spychala A; Marszalek A; Wierzchoslawska E; Cholewinski W
Mol Clin Oncol; 2018 Jan; 8(1):89-92. PubMed ID: 29399349
[TBL] [Abstract][Full Text] [Related]
16. Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor.
Zhang C; Lin KS; Bénard F
Mol Imaging; 2017; 16():1536012117737919. PubMed ID: 29182034
[TBL] [Abstract][Full Text] [Related]
17. PET and SPECT imaging of melanoma: the state of the art.
Wei W; Ehlerding EB; Lan X; Luo Q; Cai W
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):132-150. PubMed ID: 29085965
[TBL] [Abstract][Full Text] [Related]
18. Advantages and disadvantages of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary.
Yu X; Li X; Song X; Dai D; Zhu L; Zhu Y; Wang J; Zhao H; Xu W
Oncol Lett; 2016 Nov; 12(5):3785-3792. PubMed ID: 27895731
[TBL] [Abstract][Full Text] [Related]
19. The role of FDG-PET/CT in preoperative staging of sentinel lymph node biopsy-positive melanoma patients.
Frary EC; Gad D; Bastholt L; Hess S
EJNMMI Res; 2016 Dec; 6(1):73. PubMed ID: 27709489
[TBL] [Abstract][Full Text] [Related]
20. Intense FDG uptake in an intra-articular localized giant-cell tumor of the tendon sheath (pigmented villonodular synovitis) mimics metastatic melanoma.
Pallas A; Hagge R; Borys D; Hunter J
Radiol Case Rep; 2009; 4(4):343. PubMed ID: 27307839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
